59 related articles for article (PubMed ID: 7305554)
1. A study on constrictor response of dog coronary arteries to acetylsalicylic acid.
Sakanashi M; Araki H; Furukawa T; Rokutanda M; Yonemura K
Arch Int Pharmacodyn Ther; 1981 Jul; 252(1):86-96. PubMed ID: 7305554
[TBL] [Abstract][Full Text] [Related]
2. Indomethacin-induced contractions of dog coronary arteries.
Sakanashi M; Araki H; Yonemura KI
J Cardiovasc Pharmacol; 1980; 2(5):657-65. PubMed ID: 6157957
[TBL] [Abstract][Full Text] [Related]
3. Effects of nilvadipine on the cardiovascular system in experimental animals.
Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
[TBL] [Abstract][Full Text] [Related]
4. Effects of calcium-antagonistic coronary vasodilators, nifedipine and verapamil, on ventricular automaticity of the dog.
Endoh M; Yanagisawa T; Taira N
Naunyn Schmiedebergs Arch Pharmacol; 1978 Apr; 302(2):235-8. PubMed ID: 652065
[TBL] [Abstract][Full Text] [Related]
5. Isolated dog coronary arteries response to glomerulopressin.
del Castillo E; Arany E; Bonetto R; Uranga J
Horm Metab Res; 1985 Apr; 17(4):194-6. PubMed ID: 4007769
[TBL] [Abstract][Full Text] [Related]
6. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
[TBL] [Abstract][Full Text] [Related]
7. The cardiac effects of prostaglandins and their modification by the prostaglandin antagonist N-0164.
Allan G; Levi R
J Pharmacol Exp Ther; 1980 Jul; 214(1):45-9. PubMed ID: 6993659
[TBL] [Abstract][Full Text] [Related]
8. Effects of Bay k 8644 and nifedipine on isolated dog cerebral, coronary and mesenteric arteries.
Asano M; Aoki K; Suzuki Y; Matsuda T
J Pharmacol Exp Ther; 1987 Nov; 243(2):646-56. PubMed ID: 2445956
[TBL] [Abstract][Full Text] [Related]
9. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin D2 (PGD2)--a potent coronary vasoconstrictor agent in the guinea pig isolated heart.
Schrör K
Naunyn Schmiedebergs Arch Pharmacol; 1978 Mar; 302(1):61-2. PubMed ID: 652054
[TBL] [Abstract][Full Text] [Related]
11. Vasodilator action of KB-944, a new calcium antagonist.
Morita T; Yoshino K; Kanazawa T; Ito K; Nose T
Arzneimittelforschung; 1982; 32(9):1037-42. PubMed ID: 6890822
[TBL] [Abstract][Full Text] [Related]
12. Cardiotonic and coronary vasodilator responses to milrinone, forskolin, and analog P87-7692 in the anesthetized dog.
Lebedinsky Y; Nordstrom ST; Aschoff SE; Kapples JF; O'Malley GJ; Kosley RW; Fielding S; Hubbard JW
J Cardiovasc Pharmacol; 1992 May; 19(5):779-89. PubMed ID: 1381777
[TBL] [Abstract][Full Text] [Related]
13. The effects of vasopressin in isolated rat hearts.
Kaygisiz Z; Kabadere TE; Dernek S; Erden SH
Indian J Physiol Pharmacol; 2001 Jan; 45(1):54-62. PubMed ID: 11211571
[TBL] [Abstract][Full Text] [Related]
14. Contractile activity of human coronary arteries and human myocardium in vitro and their sensitivity to calcium entry blockade by nifedipine.
Godfraind T; Finet M; Lima JS; Miller RC
J Pharmacol Exp Ther; 1984 Aug; 230(2):514-8. PubMed ID: 6589392
[TBL] [Abstract][Full Text] [Related]
15. Effects of the water extract of Chrysanthemum indicum Linn. on coronary and systemic hemodynamics in the dog.
Kato T; Noguchi K; Sakanashi M; Miyamoto Y; Suekawa M; Aburada M; Hosoya E
Arch Int Pharmacodyn Ther; 1986 Apr; 280(2):241-53. PubMed ID: 3718087
[TBL] [Abstract][Full Text] [Related]
16. Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog.
Sybertz EJ; Watkins RW; Baum T; Pula K; Rivelli M
J Pharmacol Exp Ther; 1985 Jan; 232(1):156-62. PubMed ID: 3917504
[TBL] [Abstract][Full Text] [Related]
17. Effects of a new beta-adrenoceptor blocking agent, S-596 (arotinolol), on isolated dog coronary arteries.
Sakanashi M; Miyamoto Y; Takeo S; Noguchi K
Arch Int Pharmacodyn Ther; 1983 Jun; 263(2):208-16. PubMed ID: 6192776
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of constrictor responses of dog coronary artery by atropine. A possible effectiveness of atropine on variant form of angina pectoris.
Sakanashi M; Furukawa T; Horio Y
Jpn Heart J; 1979 Jan; 20(1):75-82. PubMed ID: 449044
[TBL] [Abstract][Full Text] [Related]
19. Effect of nisoldipine on coronary resistance, contractility and oxygen consumption of the isolated blood-perfused canine left ventricle.
Schipke JD; Burkhoff D; Alexander J; Schaefer J; Sagawa K
J Pharmacol Exp Ther; 1988 Mar; 244(3):1000-4. PubMed ID: 3252017
[TBL] [Abstract][Full Text] [Related]
20. Effects of exogenous vasoconstrictors on coronary vascular resistance and prostacyclin production of the quiescent heart: the inhibitory effect of aspirin.
Lee SL; Levitsky S; Feinberg H
J Pharmacol Exp Ther; 1989 Jan; 248(1):44-9. PubMed ID: 2492343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
